Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDistrib. Fin. Regulatory News (DFCH)

Share Price Information for Distrib. Fin. (DFCH)

Share Price is delayed by 15 minutes
Get Live Data
54.50    0.50 (0.93%)
Bid:
54.00
Ask:
55.00
Spread: 1.00 (1.852%)
Market Cap: £89.43m
DFCH Live PriceLast checked at - London Stock Exchange

Intraday Distrib. Fin. Share Chart

Trading Update

6 Dec 2024 07:00

RNS Number : 0288P
Distribution Finance Cap. Hldgs PLC
06 December 2024
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation (EU no. 596/2014) as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended from time to time).

 

6 December 2024

 

Distribution Finance Capital Holdings plc

("DF Capital" or the "Company" together with its subsidiaries the "Group")

 

 

Trading Update

Full year results expected to be significantly ahead of market expectations

 

Distribution Finance Capital Holdings plc, a specialist bank providing working capital solutions to dealers and manufacturers across the UK, is pleased to provide a trading update for the 12 months ending 31 December 2024.

Trading Update

Loan origination continues to perform in line with expectations and as a result its loan book will end the year in the range of £650-700m.The Group's net interest margin ('NIM') continues to perform ahead of expectations, with operating costs being well managed and cost of risk running well below the Group's target of 1%. Accordingly, the Group expects its full year underlying pre-tax profit (excluding recoveries and write-backs relating to RoyaleLife) to be significantly ahead of market expectations at not less than £14m, more than a threefold increase on its FY23 outturn (FY23: £4.6m).

Additionally, the Group is pleased to confirm that it has updated its expected credit loss provision relating to RoyaleLife, having now successfully secured the previously reported £3m settlement against property that is currently pending sale and is subject to a new counterparty loan. This settlement was originally expected to be recognised in FY25. Accordingly, the Group will write-back a further £3.0m of credit loss provisions bringing the total recovery relating to RoyaleLife for FY24 to £4.7m. As a result, total pre-tax profit for the 12 months ending 31 December 2024 is expected to be significantly ahead of market expectations at not less than £18.7m, more than a fourfold increase on its FY23 outturn.

The Group continues to make good progress in the build of its asset finance/hire purchase lending capability, having now fully completed its application to the Financial Conduct Authority for consumer lending permission. The launch of this product, which remains on track for H1 2025, is expected to result in a significant expansion of our market opportunity with the addressable market for asset finance being several times larger than the Group's existing core lending product. This product will be distributed through the Group's existing dealer and manufacturer customers to end-user obligors. The Group will provide a further update on progress in due course.

The Company expects to announce its full year trading update in mid-January 2025.

Carl D'Ammassa, Chief Executive, commented: "2024 marks another year of strong delivery and execution against our business plan. The Group remains well positioned in its strategy to become a multi-product lender and we remain excited by the level of interest in our asset finance product ahead of its expected launch in the first half of 2025."

 

The person responsible for arranging the release of this announcement on behalf of the Company is Karen D'Souza (Company Secretary).

 

 

For further information contact:

Distribution Finance Capital Holdings plc

 

Carl D'Ammassa - Chief Executive Officer

+44 (0) 161 413 3391

Kam Bansil - Head of Investor Relations

+44 (0) 7779 229508

http://www.dfcapital-investors.com

 

 

 

Panmure Liberum Limited (Nomad and Broker)

 +44 (0) 203 100 2000

Chris Clarke

 

William King

 

Anake Singh

 

 

Alma Strategic Communications

+44 (0) 203 405 0235

Josh Royston

 

Hilary Buchanan

 

Kieran Breheny

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIEFELEIIS
Date   Source Headline
30th Sep 20223:23 pmRNSDirector/PDMR Shareholding
30th Sep 20223:02 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSHalf-year Report
13th Sep 20229:15 amRNSNotice of Results
3rd Aug 202210:53 amRNSHolding(s) in Company
11th Jul 20227:00 amRNSQ2 Trading Update
15th Jun 202212:52 pmRNSResult of AGM
9th Jun 20224:45 pmRNSDirector/PDMR Shareholding
24th May 202210:23 amRNSNotice of AGM
12th May 20223:45 pmRNSDirector/PDMR Shareholding
12th May 20222:40 pmRNSDirector/PDMR Shareholding
12th May 20229:04 amRNSDirector/PDMR Shareholding
9th May 20223:11 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSDirectorate Change
13th Apr 20227:00 amRNSFinal Results
4th Apr 20227:00 amRNSQ1 Trading Update
16th Mar 20229:30 amRNSHolding(s) in Company
16th Mar 20229:30 amRNSHolding(s) in Company
16th Mar 20229:30 amRNSHolding(s) in Company
23rd Feb 20225:13 pmRNSHolding(s) in Company
21st Feb 20224:31 pmRNSHolding(s) in Company
9th Feb 20227:00 amRNSAppointment of Independent Non-Executive Chair
26th Jan 20229:35 amRNSHolding(s) in Company
18th Jan 20228:19 amRNSProgressive publishes new research
18th Jan 20227:00 amRNSTrading Update
14th Dec 20215:03 pmRNSHolding(s) in Company
14th Dec 20214:58 pmRNSHolding(s) in Company
14th Dec 202110:02 amRNSHolding(s) in Company
13th Dec 20213:27 pmRNSHolding(s) in Company
13th Dec 202112:22 pmRNSHolding(s) in Company
10th Dec 20214:42 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
10th Dec 20213:05 pmRNSDirector/PDMR Shareholding
10th Dec 202112:17 pmRNSHolding(s) in Company
10th Dec 202111:16 amRNSDirectorate Change
10th Dec 20217:00 amRNSResult of Secondary Placing
9th Dec 20214:51 pmRNSProposed Secondary Placing
7th Dec 20217:47 amRNSProgressive publishes new research
6th Dec 20217:00 amRNSTrading Update
5th Oct 20217:00 amRNSThird Quarter Loan Book
23rd Sep 20217:32 amRNSProgressive publishes new research
23rd Sep 20217:00 amRNSHalf-year Report
13th Sep 20214:48 pmRNSHolding(s) in Company
3rd Sep 20214:28 pmRNSHolding(s) in Company
9th Jul 20217:51 amRNSProgressive publishes new research
2nd Jul 20217:00 amRNSQ2 Trading Update
19th May 20212:12 pmRNSResult of AGM
19th May 202111:48 amRNSDirectorate Change and Withdrawal of Resolution
4th May 20211:00 pmRNSChange of Registered Office
21st Apr 20217:26 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.